Vardenafil, sold under the brand name Levitra, is a prescription drug used to treat erectile dysfunction in men. The drug boosts blood flow to the penis to maintain an erection.
Originally created and sold by Bayer Pharmaceuticals, the drug’s patent expired in October 2018. Since then, generic versions of Levitra have flooded the market. Crossmedia SA, Teva Pharms, and Zydus Pharms all offer generic versions of the drug, available in three doses (5mg, 10mg, and 20mg). Only Levitra continues to be available at a dose of 2.5mg.
But just because a medication is available generically, does not mean it can be purchased without a prescription. And in the case of erectile dysfunction medication, it’s not advisable to shop for the pills online without consulting a doctor first.
Vardenafil has some serious side effects. They include headaches, flushing, heartburn, dizziness, nausea and back pain. The drug may also interact negatively with other prescription drugs or supplements. If you suffer from underlying medical conditions, only a doctor will be able to assess if vardenafil is safe to use.
In many cases, erectile dysfunction accompanies serious medical conditions such as diabetes, obesity, heart disease, hypertension, depression, low testosterone, and high cholesterol. By assessing the causes of your erectile dysfunction, more effective treatment options can be provided.
Always speak to a doctor before taking prescription medications. If you opt for an online pharmacy, make sure you choose a trustworthy service that provides a medical assessment with an online doctor.
- "Levitra: Uses, Dosage, Side Effects - Drugs.com". in , , 2019, <https://www.drugs.com/levitra.html> [accessed 2 October 2019].
- "Generic Levitra Availability - Drugs.com". in , , 2019, <https://www.drugs.com/availability/generic-levitra.html> [accessed 2 October 2019].
- Turk, S, Y Solak, S Kan, H Atalay, M Kilinc, & E Agca et al., "Effects of sildenafil and vardenafil on erectile dysfunction and health-related quality of life in haemodialysis patients: a prospective randomized crossover study.". in Nephrology Dialysis Transplantation, 25, 2010, 3729-3733.